Results 181 to 190 of about 133,046 (390)

An evaluation of azathioprine in severe chronic asthma [PDF]

open access: bronze, 1971
N. G. Hodges   +2 more
openalex   +1 more source

Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open‐label, prospective and randomised clinical trial

open access: yesAlimentary Pharmacology and Therapeutics, 2017
X. Roblin   +11 more
semanticscholar   +1 more source

Predictors of systemic sclerosis patients with interstitial lung disease progression: A retrospective study

open access: yesRheumatology &Autoimmunity, EarlyView.
The final systemic sclerosis patients with interstitial lung disease (SSc‐ILD) progression prediction model was composed of 6 significant risk factors: male, type 2 diabetes mellitus, pericardial effusion, anti‐Ro52, hypoproteinemia, and elevated C‐reactive protein. Our model demonstrated excellent prognostic utility.
Xi Cao   +6 more
wiley   +1 more source

Further Experience with Azathioprine in Rheumatoid Arthritis [PDF]

open access: bronze, 1971
Judi Harris   +2 more
openalex   +1 more source

Hypersensitivity to azathioprine

open access: yesJournal of Dermatological Treatment, 1991
S. Veraldi, R. Caputo
openaire   +2 more sources

Urticarial Plaques With Vesicles in a Young Hispanic Woman

open access: yes
JEADV Clinical Practice, EarlyView.
Valeria Olvera‐Rodríguez   +6 more
wiley   +1 more source

Pancreatic Enzyme Replacement Therapy Improves Exclusive Enteral Nutrition Related Diarrhea in Crohn's Disease: A Prospective Randomized Trial

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Background & Aims Previous results showed that combined treatment of biologics and exclusive enteral nutrition (EEN) brought moderate‐to‐severe Crohn's disease patients significant improvements in clinical and endoscopic outcomes. Despite its essential role and favorable safety profile, EEN in the treatment of adult Crohn's disease is ...
Jian Kang   +12 more
wiley   +1 more source

Differences in the Fecal Metabolome of Autoimmune Pancreatitis Patients

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Background Chronic pancreatitis is a risk factor for pancreatic cancer. Autoimmune pancreatitis is a unique form of chronic pancreatitis that is primarily characterized by its immune mediate etiology, clinically resembling pancreatic cancer, yet uniquely responsive to steroid treatment.
Vladyslav Dovhalyuk   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy